The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.

Novo Nordisk, the Danish pharmaceutical company known for its weight-loss drug Wegovy and diabetes medicine Ozempic, has ...

The biopharma job market remains challenging, based on BioSpace data. In August, job postings live on the website dropped 32% ...

Wegovy-maker Novo Nordisk said on Thursday it had told all its staff to return to the office as the drugmaker's new CEO tries ...

Novo Nordisk - makers of Ozempic - is set to lay off 9,000 staff members, or 11.5 % of its workforce. Five thousand of the ...

Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it would cut 9,000 jobs, 5,000 ...

Wall Street inched to more records on Wednesday following a surprisingly encouraging report on inflation and a stunning forecast for growth from Oracle because of the artificial intelligence boom.

The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.

At their heights, Denmark’s corporate champions seemed untouchable. Novo Nordisk A/S, long known mostly as an insulin maker, was Europe’s most valuable company last year, after riding a surge of ...

Sandwich maker Potbelly is being acquired by the gas station and convenience store chain RaceTrac for $566 million. Potbelly, ...

Wall Street closed mostly higher to notch more records. The S&P 500 added 0.3% Wednesday and set an all-time high for a ...